Find Academic Supervisors

David A PalmerView profile

Professor

• Anthropology of Religion
• Sociology of Spirituality
• Daoism
• +7 more

Professor David A Palmer is a distinguished academic jointly appointed by the Hong Kong Institute for the Humanities and Social Sciences and the Department of Sociology at the University of Hong Kong, where he has been teaching since 2008. His interdisciplinary work bridges anthropology, sociology, religious studies, and Sinology, establishing him as a leading scholar in Chinese religious studies and transnational religious movements. Palmer's educational background includes a PhD in Anthropology of Religion from Ecole Pratique des Hautes Etudes (Sorbonne, Paris), an MPhil in Clinical Psychology/Medical Anthropology from University of Paris-VIII, and a BA in Anthropology and East Asian Studies from McGill University. His scholarly contributions span multiple disciplines with particular emphasis on Chinese religious traditions and their global manifestations. His research interests focus on the anthropology and sociology of spirituality and religion, especially Daoism and Chinese religion; religion in modern and contemporary China; inter-Asian and transnational religious circulations; Baháʼí Faith; civil society, volunteering, philanthropy, community engagement; and cultural and religious interactions on the Belt and Road. His work examines how religious traditions navigate modernity, state power, and globalization, with particular attention to the Belt and Road Initiative's cultural dimensions. Palmer's publications reveal a consistent focus on understanding Chinese religious traditions within broader theoretical frameworks of social theory, civil society, and transnational religious networks. His articles demonstrate how Chinese religious practices and institutions both adapt to and shape contemporary social and political contexts, with particular attention to the intersections of spirituality, modernity, and state-society relations. Joseph Levenson Award of the Association for Asian Studies PROSE award of the American Publishers' Association Francis L.K. Hsu Award of the Society for East Asian Anthropology Edward Bruner Prize for the best book in Anthropology of Tourism HK Research Grants Council RGC Research Fellowship (2021-2025) HK Research Grants Council Humanities and Social Sciences Prestigious Fellowship (2019) Palmer currently leads multiple significant research projects including 'Global China, Local Cultures: Chinese Modernity and Soft Power on the Belt and Road' (RGC Research Fellowship, 2021-2025), 'Infrastructures of Faith: Religious Mobilities on the Belt and Road' (CRF, 2019-2023), 'Rituals and Manuscripts of the Lanten Yao (Laos)' (GRF, 2021-2024), and 'Religious Cosmopolitanism in China, 1895-1927' (GRF, 2021-2024). He leads the 'Asian Religious Connections' research cluster at HKIHSS, co-convenes the 'Culture, Community and Social Equity' research cluster in the HKU Faculty of Social Sciences, and serves as co-convenor of the HKU Anthropology Research Network. As President of the East Asian Society for the Scientific Study of Religion, he plays a key role in advancing scholarly understanding of religion in the region.

Chua Tat SengView profile

Professor

• unstructured data analytics
• multimedia information retrieval
• recommendation systems
• +6 more

Chua Tat Seng is a Professor at the School of Computing, National University of Singapore (NUS), holding the KITHCT Chair Professorship since 2009. He serves as co-Director of the NExT++ Center, a joint research center between NUS and Tsinghua University focused on Extreme Search. His academic career spans over three decades at NUS, where he has held various leadership positions including Acting Dean of the School of Computing (1998-2000) and Acting Head of the Department of Information Systems & Computer Science (1996-1998). Professor Chua's research spans unstructured data analytics , multimedia information retrieval , recommendation and conversation systems , and emerging applications in e-commerce and fintech . He established the Lab for Media Search (LMS) at the School of Computing and has been instrumental in advancing multimodal learning and search technologies. His work bridges theoretical foundations with practical applications, particularly in developing trustable AI systems for real-world deployment. His recent publications demonstrate a strong focus on large language models for recommendation systems , multimodal learning , and generative AI applications . The research trends show increasing emphasis on LLM-based recommendation, multimodal understanding, and addressing fundamental challenges in AI reliability, fairness, and efficiency. His work spans theoretical advancements in representation learning to practical applications in e-commerce, finance, and healthcare domains. ACM SIGMM Technical Achievement Award 2015 Multiple Best Paper Awards across ACM Multimedia, IEEE Transactions, and MMM conferences (2007-2020) Professor Chua has supervised 37 PhD students since 2004, establishing himself as a dedicated mentor in the academic community. His research has been supported by substantial grants including NExT++ ($12 million), Base Metals Price Forecasting ($200,000), and Multilingual Multimodal Knowledge Graph ($500,000). He maintains active collaborations with Tsinghua University, University of Southampton, and industry partners like Four Elements Capital and Singapore Press Holdings. As co-Director of the NExT++ Center, he leads a major research initiative focused on Web Intelligence and User Empowerment. His visiting professorships at Tsinghua University (2017-present) and Zhejiang University (2021-present) reflect his international impact in the field of multimedia and AI research.

Rhonda GoldmanView profile

Professor

• Clinical Psychology
• Emotion-Focused Therapy
• Psychotherapy
• +7 more

Rhonda Goldman is a Full Professor in the Clinical Psychology Department at The Chicago School of Professional Psychology in Chicago, Illinois. She is a licensed Clinical Psychologist in Illinois and runs her private practice, Emotion-focused Therapy, Chicago, where she sees both couples and individuals. Dr. Goldman is a founding board member of the International Society of Emotion-focused Therapy and serves as President of the Emotion-focused Therapy Institute. Dr. Goldman earned her academic credentials from York University in Toronto, Ontario, Canada, receiving her Bachelor of Arts in 1987, Master of Arts in 1991, and Doctor of Philosophy in Clinical Psychology in 1997. She taught at the Illinois School of Professional Psychology for 22 years before transitioning to her current position at The Chicago School of Professional Psychology following the closure of the Illinois School. Dr. Goldman is a leading expert in Emotion-Focused Therapy (EFT), a therapeutic approach that integrates elements of client-centered therapy, Gestalt therapy, and modern emotion theory. Her research focuses on EFT for couples, emotional processes, empathy, vulnerability, depression, case formulation, and self-soothing. She has authored six texts on EFT and two professional videos published by the American Psychological Association. Dr. Goldman teaches graduate courses in Humanistic and Experiential Psychotherapy, Psychotherapy Seminars, and Emotion-Focused Therapy, emphasizing the importance of emotional processing in therapeutic change. Dr. Goldman's publications demonstrate a consistent focus on advancing Emotion-Focused Therapy through both theoretical development and practical application. Her work spans individual therapy, couples therapy, case formulation, and therapist training, with recent emphasis on adapting EFT for online delivery. Her research shows how emotional awareness and processing serve as central mechanisms of change in psychotherapy, with applications across various clinical issues including depression and relationship distress. Dr. Goldman is actively involved in professional organizations that support the development and dissemination of Emotion-Focused Therapy. She serves as a founding board member of the International Society for Emotion-focused Therapy, past-president of the Society for the Exploration of Psychotherapy Integration, Action-Editor for the Journal of Person-centered and Experiential Psychotherapies, and member of the Society for Psychotherapy Research. As an educator and clinician, Dr. Goldman has mentored numerous professionals in the field of psychotherapy. She travels internationally conducting training workshops for mental health professionals in Emotion-focused therapy for Couples and Individuals across Europe, Asia, and North America. Her work bridges research and practice, emphasizing the importance of emotional processing in therapeutic change while maintaining a strong commitment to evidence-based practice. Dr. Goldman co-founded the Emotion-focused Therapy Institute (EFTI), which facilitates and fosters training and educational opportunities for psychologists and therapists interested in incorporating EFT into their professional practices. Through EFTI and her international workshops, she has created a global community of practitioners dedicated to advancing Emotion-Focused Therapy.

Robert RohlingView profile

Professor

• Biomedical Engineering
• Medical Imaging
• Medical Information Systems
• +3 more

Robert Rohling is a Professor at the University of British Columbia's Faculty of Applied Science, affiliated with the Department of Mechanical Engineering and holding a joint appointment with the Department of Electrical and Computer Engineering. As Director of the Institute of Computing, Information and Cognitive Systems (ICICS), his research focuses on biomedical engineering, medical imaging, robotics, and computational methods. B.A.Sc. (UBC) M.Eng. (McGill) Ph.D. (Cambridge) Rohling's work spans three primary research areas: medical imaging (3D ultrasound, spatial compounding, elasticity reconstruction), medical information systems (radiologist navigation tools for large image datasets), and robotic calibration for surgical applications. His multidisciplinary approach integrates mechanical and electrical engineering principles with clinical needs. Rohling's publications (2020-2022) reveal trends in advanced ultrasound techniques (e.g., shear wave vibro-elastography), AI-driven image processing (cycleGAN translation), and computational optimization for diagnostic accuracy. Keywords across his work include Medical Imaging, Biomedical Engineering, Robotics, and Computational Modeling. As director of the Robotics and Control Laboratory , Rohling leads interdisciplinary collaborations with industry and clinical partners to address practical challenges in medical diagnostics and surgical robotics. His research emphasizes translating engineering innovations into clinical practice.

• Bioinformatics
• Machine Learning
• Deep Learning
• +5 more

Ole Winther is Professor in High dimensional biological data analysis/Machine learning at the Department of Biology, University of Copenhagen and Professor in Data science and complexity at DTU Compute, Technical University of Denmark. He serves as CRO and co-founder of raffle.ai, CTO and co-founder of FindZebra, Head of ELLIS Unit Copenhagen, and co-PI of the Machine Learning for Life Science Center. His research spans Bioinformatics , Machine Learning , and AI for Science , focusing on applying deep learning to biological sequence analysis, latent variable models, and medical NLP. Winther's work develops predictive and generative models for bioinformatics, with significant contributions to protein localization tools (SignalP, DeepLoc, DeepTMHMM), single-cell genomics, and novel deep learning architectures like variational autoencoders and diffusion models. Analysis of Winther's recent publications (2023-2025) reveals a strong trend toward integrating protein language models with traditional bioinformatics approaches and applying diffusion models to scientific problems. His work bridges theoretical machine learning advancements with practical applications in biology and medicine, particularly in protein sequence analysis, medical search engines, and scientific simulation acceleration. Winther currently supervises a diverse research group including Panagiotis Antoniadis, Rachael M. DeVries, Jun Wang, Beatrix M. G. Nielsen, Felix G. Teufel, Irene R. Rodriguez, Anders Christensen, and Christopher Heje Grønbech. His former students have established successful careers at institutions including Google, Apple, and various startups, with notable alumni like Casper Sønderby (Google Brain) and Søren Sønderby (Apple). He leads significant research initiatives including the ELLIS Unit Copenhagen and the Machine Learning for Life Science Center, while maintaining active industry partnerships through his co-founded companies raffle.ai (enterprise search using NLP) and FindZebra (search engine for rare diseases). His teaching includes Deep Learning courses at both DTU (02456) and University of Copenhagen (NDAK24002U).

Bobak MortazaviView profile

Associate Professor

• Medical analytics
• Machine learning
• Embedded systems design
• +3 more

Bobak Mortazavi is an Associate Professor in the Department of Computer Science & Engineering at Texas A&M University. His research focuses on medical analytics, machine learning, wearable sensors, and cyber-physical systems. He leads interdisciplinary projects in healthcare technology, including AI-driven diagnostics and predictive modeling for cardiovascular diseases. He has received notable awards such as the Best Demonstration Award at IEEE EMBS 2012 and the Best Paper Award at the Fourth International Conference on Data Analytics 2015. His work bridges machine learning with clinical applications, emphasizing practical solutions for healthcare challenges. Recent research includes developing AI tools for aortic stenosis detection, electrolyte estimation via ECG, and real-time patient monitoring systems. He collaborates with industry and academic partners to advance telemedicine and wearable health technologies. Key contributions include the SMART-LV project for smartphone-based cardiac diagnostics and the ArterialNet framework for blood pressure reconstruction using wearable sensors. His work is published in top journals like IEEE Journal of Biomedical and Health Informatics and Elsevier's Pervasive and Mobile Computing.

Camila AquinoView profile

Assistant Professor

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +5 more

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

Maria CraigView profile

Professor

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +4 more

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

Peter BühlmannView profile

Professor

• High-dimensional Statistics
• Causal Inference
• Machine Learning
• +3 more

Peter Bühlmann is a Professor at ETH Zürich within the Seminar für Statistik , focusing on high-dimensional statistics, causal inference, and machine learning. His work bridges theoretical advancements with practical software implementations in R packages like pcalg , mboost , and glmmlasso , impacting fields such as genomics, proteomics, and intensive care analytics. Key Contributions : Causal structure learning, stability selection, anchor regression, and deconfounding. Software : Developed widely used R packages for statistical modeling and causal inference. Teaching : Courses on high-dimensional statistics at ETH Zürich and international institutions. Research Trends : Recent articles emphasize causal robustness, domain adaptation, and applications in medicine. His work addresses challenges in heterogeneous data, missing values, and covariate shifts using methods like spectral deconfounding and residual prediction tests. Scientific Recognition : Co-author of a paper designated as a New Hot Paper (Meinshausen and Bühlmann, 2006) by Essential Science Indicators, indicating significant impact in high-dimensional multiple testing.

• Food Business Management
• Food Innovation
• Innovation Management
• +7 more

Dimitrios Skalkos serves as a Professor at the Department of Chemistry, University of Ioannina, holding the specific title of Professor of Innovation Management in Food Businesses. His office is located in building X2, room X2-206c on the Ioannina Campus (45110 Ioannina), and he leads the Food Chemistry Laboratory. He earned his Basic Degree in Chemistry from the University of Ioannina (1980-1985) followed by a Doctoral Degree from the University of Toledo, USA (1986-1989) with dissertation research on "Di- and Tetrahydroporphyrins: Syntheses and Antitumor Activities". Skalkos's research spans Food Business Management, Food Innovation, and Innovation Management, with specialized focus on Innovation & Entrepreneurship, Aromatic Plants, Innovative Foods, and Strategic Marketing. His work bridges academic research with industry applications in food systems, emphasizing Greek agricultural products and pandemic-era consumer behavior. His 36 publications (2020-2024) reveal strong trends in post-pandemic food innovation, consumer perception of traditional Greek foods, functional food development (particularly olive oil, cheese, and grape by-products), and sustainable agri-food supply chains. Key thematic clusters include traceability systems, bioactive properties of novel foods, and economic impacts on food choices. He has actively supervised Master's and PhD students through departmental presentations, directed 23 research programs, and organized 15 seminars and conferences. His laboratory website ( https://foods.chem.uoi.gr ) showcases ongoing food chemistry innovations.

Jimeng SunView profile

Professor

• Artificial Intelligence
• Healthcare Analytics
• Drug Discovery
• +5 more

Dr. Jimeng Sun is a Health Innovation Professor at the Siebel School of Computing and Data Science and Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign. Co-founder of Keiji AI , he leads groundbreaking research at the intersection of artificial intelligence and healthcare, actively deploying clinical AI systems and developing frameworks like PyHealth and Therapeutics Data Commons . His research spans four major areas: Clinical AI Systems : Developing interpretable models (e.g., RETAIN) for patient similarity, temporal event prediction, medication recommendation, and clinical outcome forecasting Drug Discovery : Creating molecular optimization frameworks, drug-target interaction models, and AI-driven platforms Clinical Trials : Pioneering patient-trial matching, outcome prediction, and optimization frameworks using deep learning and graph neural networks Biosignal Analysis : Advancing sleep staging, seizure classification, and automated EEG/Cardiac monitoring systems With over 500 top-tier publications (including in Nature , NEJM AI , and leading AI conferences) and an h-index of 99, his work has been recognized with the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare award. He maintains active collaborations with institutions like Massachusetts General Hospital , Medidata Solutions , and OSF Healthcare . His recent publications reveal a strong focus on: Reinforcement learning applications in medical data analysis Large language model adaptation for clinical tasks Knowledge graph integration with AI systems Synthetic data generation for healthcare Multi-modal learning in clinical contexts Explainable AI for medical applications Dr. Sun's lab ( Sunlab ) emphasizes practical impact over theoretical work, actively collaborating with hospitals and healthtech companies. He welcomes contributions from clinicians, researchers, and industry partners through initiatives like his AI for Health webinar series .

Nuno ConceiçãoView profile

Assistant Professor

• Clinical Psychology
• Psychotherapy Integration
• Personality Disorders
• +3 more

Nuno Conceição serves as an Invited Assistant Professor at the Faculty of Psychology, University of Lisbon (FP-UL), where he has taught since 2011. His clinical work focuses on adults with complex trauma, personality disorders, and structural dissociation of the personality. He earned his BA (1999), MA (2006), and Ph.D. in Clinical Psychology (2011) from FP-UL, following his Abitur at the German School of Lisbon (1994). BA: FP-UL (1999) MA: FP-UL (2006) Ph.D.: FP-UL (2011) His research centers on Psychotherapy Integration, examining General Change Processes, Case Formulation, Emotional Change in Trauma Therapy, and Ecological Dimensions in Psychotherapy. He investigates how experiential processing facilitates change in personality pathology through integrative clinical decision-making. Key trends in his 2016-2023 publications reveal consistent focus on transdiagnostic mechanisms, termination processes, and musical interventions for emotional processing, primarily using qualitative case studies to advance psychotherapy integration frameworks. No scientific awards were documented in the source material. Conceição has supervised over 50 master's research projects and designed the Integrative Perspectives in Psychotherapy curriculum. He directs the Paradigmatic Complementarity Lab—a practice-based research network using process coding to train clinical skills—and serves as a therapist trainer/supervisor at OneSession.org. Supervision: >50 master's projects Curriculum Development: Integrative Perspectives in Psychotherapy Professional Training: OneSession.org The Paradigmatic Complementarity Lab drives his research agenda, utilizing process-coding methodologies to study change mechanisms in complex trauma and personality disorders within real-world clinical settings.

• Financial Contracting
• Corporate Disclosure
• Corporate Investment Behavior
• +5 more

Clemens Otto is a Full-time Associate Professor of Finance at the Lee Kong Chian School of Business, Singapore Management University. He holds a Ph.D. (Finance) from London Business School (2012), an M.Res. (Finance) from London Business School (2009), and a CEMS Master (International Management) and Dipl.-Kfm. (Business Administration) from the University of Cologne and HEC Paris (2006). His research focuses on Financial Contracting, Corporate Disclosure Practices, Behavioral Finance, and Strategic Investment Decisions. Key research interests include analyzing how disclosure policies impact capital markets, the behavioral drivers of corporate investment, and the effects of regulatory frameworks on firm behavior. His work integrates theoretical finance with empirical evidence from supply chains, healthcare disclosures, and debt markets. Notable awards include the Michael J. Brennan Award (2022) and the SAC Capital Ph.D. Award (2012). His publications span journals such as the Review of Financial Studies , Management Science , and The Accounting Review . Current research explores disclosure externalities in supply chains and the strategic implications of peer disclosures in clinical trials. Prof. Otto has been affiliated with SMU since 2017, advancing through roles from Assistant Professor (2017–2021) to his current position. His expertise aligns with SMU’s strategic priorities in Asia-focused finance and sustainable living through informed corporate governance frameworks.

Aleksandar JeremicView profile

Associate Professor

• Biomedical Signal Processing
• Statistical Signal Processing
• Biometrics
• +7 more

Aleksandar Jeremic is an Associate Professor in both the Electrical & Computer Engineering department and the McMaster School of Biomedical Engineering at McMaster University. His research focuses on biomedical signal processing, statistical signal processing, and biometrics, with applications in healthcare and biomedical systems. He holds a Dipl. Ing. from the University of Belgrade, and an M.S. and Ph.D. from the University of Illinois at Chicago. His expertise spans physiological signal analysis (e.g., ECG/EEG), medical imaging, and machine learning for biomedical applications. He has authored over 50 technical articles and two book chapters, and has been recognized with a teaching award from the McMaster Electrical and Computer Engineering Society (2018). He supervises graduate students in both theoretical and applied research areas. Dr. Jeremic teaches advanced courses such as Biomedical Signal Modeling and Processing and Advanced Probability and Random Processes , emphasizing practical applications of signal processing in healthcare. His work includes clinical implementations like neonatal seizure monitoring software and microwave imaging for breast cancer detection.

• Lymphoma
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• +5 more

Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.